Topically Applied Heparins for the Treatment of Vascular Disorders

[1]  L. Hofmann,et al.  Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline , 2007, Annals of Internal Medicine.

[2]  C. Apperson-Hansen,et al.  The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre st , 2006, European heart journal.

[3]  C. Ko,et al.  The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. , 2006, Archives of surgery.

[4]  J. Seménka,et al.  Liposomal Heparin Spray: A New Formula in Adjunctive Treatment of Superficial Venous Thrombosis , 2005, Angiology.

[5]  H. Büller,et al.  Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism : a systematic review , 2005 .

[6]  M. Griffin,et al.  Four-week treatment with Essaven gel in diabetic microangiopathy--a placebo-controlled, randomized study. , 2001 .

[7]  M. Griffin,et al.  Changes in Microcirculation in Venous Ulcers with Essaven Gel , 2001, Angiology.

[8]  M. Griffin,et al.  Treatment of superficial vein thrombosis with standardized application of Essaven gel--a placebo-controlled, randomized study. , 2001, Angiology.

[9]  M. Griffin,et al.  Microvascular Changes in Venous Hypertension due to Varicose Veins After Standardized Application of Essaven Gel , 2001, Angiology.

[10]  M. Griffin,et al.  Microvascular Alterations in Diabetic Microangiopathy: Topical Treatment with Essaven Gel , 2001, Angiology.

[11]  G. Belcaro,et al.  Topical Treatment of Venous Microangiopathy in Patients with Venous Ulceration with Essaven Gel , 2001, Angiology.

[12]  M. Griffin,et al.  Two-Week Topical Treatment with Essaven Gel in Patients with Diabetic Microangiopathy , 2001, Angiology.

[13]  M. Griffin,et al.  Microangiopathy and Venous Ulceration: Topical Treatment with Essaven Gel , 2001, Angiology.

[14]  M. Griffin,et al.  Treatment of Superficial Vein Thrombosis: Clinical Evaluation of Essaven Gel , 2001, Angiology.

[15]  K. Soma,et al.  In Response , 2001 .

[16]  E. Lévy,et al.  The 1999 French Venous Disease Survey: Epidemiology, Management, and Patient Profiles , 2001, Angiology.

[17]  P. Mahrer,et al.  Prevalence of Subclavian Artery Stenosis in Patients with Peripheral Vascular Disease , 2001, Angiology.

[18]  A. Magdy,et al.  Percutaneous Balloon Mitral Commissurotomy During Pregnancy , 2001, Angiology.

[19]  S. Göksel,et al.  Association Between Mitral Annular Calcification and Carotid Atheroma , 2001, Angiology.

[20]  I. Khan,et al.  Isolated Pulmonic Valve Endocarditis Caused by Group B Streptococcus ( Streptococcus agalactiae) , 2001, Angiology.

[21]  E. Madu,et al.  Recurrent Ischemia Resulting from Left Internal Mammary Artery-to-Pulmonary Artery Fistula , 2001, Angiology.

[22]  S. Yusuf,et al.  Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis , 2000, The Lancet.

[23]  M. Vilardell,et al.  Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial , 1999, European Journal of Clinical Pharmacology.

[24]  Novosad Em.  [Lioton-1000 gel in the prevention of thrombosis of the major veins of the extremities]. , 1999 .

[25]  G. G. Vlaikov,et al.  [The treatment of acute and chronic venous insufficiency of the lower extremities by using Lioton-1000 gel]. , 1999, Klinichna khirurhiia.

[26]  S. Katakkar.  Use of heparin as a topical antithrombotic and antiinflammatory agent. , 1993, Journal of the National Cancer Institute.

[27]  P. de Moerloose,et al.  Heparin-related activity in peripheral venous blood after percutaneous application of various glycosaminoglycan containing creams. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[28]  J. Brunkwall,et al.  Treatment of superficial thrombophlebitis. A comparative trial between placebo, Hirudoid cream and piroxicam gel. , 1990, Annales chirurgiae et gynaecologiae.

[29]  M. Subrahmanyam.  Topical effect of heparin and a corticosteroid in prevention of infusion thrombophlebitis. , 1988, Indian journal of physiology and pharmacology.

[30]  G. Ruotolo,et al.  [Clinical contribution to pharmacology in venous pathology and its complications. Effects of heparin in gel form]. , 1987, Minerva cardioangiologica.

[31]  C. Woodhouse.  Movelat in the prophylaxis of infusion thrombophlebitis. , 1979, British medical journal.

[32]  P. Reindl,et al.  [Controlled study on the efficacy of external treatment in surface-near thrombophlebitis]. , 1977, Fortschritte der Medizin.

[33]  J. Wójcicki,et al.  Local treatment of thrombophlebitis with essaven gel. , 1976, Archivum immunologiae et therapiae experimentalis.

[34]  V. Kakkar,et al.  Treatment of superficial thrombophlebitis: a randomized, bouble-blind trial of heparinoid cream. , 1975, British medical journal.